LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.16 Million USD | -92.97% |
| 2022 | 87.74 Million USD | -72.95% |
| 2021 | 324.38 Million USD | -28.93% |
| 2020 | 456.41 Million USD | -29.8% |
| 2019 | 650.17 Million USD | 2.18% |
| 2018 | 636.29 Million USD | 161.43% |
| 2017 | 243.38 Million USD | 0.38% |
| 2016 | 242.47 Million USD | 0.36% |
| 2015 | 241.61 Million USD | 19.07% |
| 2014 | 202.92 Million USD | 3349.85% |
| 2013 | 5.88 Million USD | -34.66% |
| 2012 | 9 Million USD | 7.59% |
| 2011 | 8.36 Million USD | -24.74% |
| 2010 | 11.11 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 2.17 Million USD | 247.37% |
| 2007 | 627 Thousand USD | -98.43% |
| 2006 | 39.9 Million USD | -76.6% |
| 2005 | 170.51 Million USD | -0.52% |
| 2004 | 171.41 Million USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 33.63 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7.58 Million USD | 22.42% |
| 2024 Q1 | 6.19 Million USD | 0.47% |
| 2023 Q2 | 11.67 Million USD | -86.84% |
| 2023 Q1 | 88.67 Million USD | 1.06% |
| 2023 Q3 | 6.32 Million USD | -45.77% |
| 2023 Q4 | 6.16 Million USD | -2.59% |
| 2023 FY | 6.16 Million USD | -92.97% |
| 2022 Q1 | 195.2 Million USD | -42.3% |
| 2022 FY | 87.74 Million USD | -72.95% |
| 2022 Q2 | 144.61 Million USD | -25.92% |
| 2022 Q4 | 87.74 Million USD | -22.95% |
| 2022 Q3 | 113.88 Million USD | -21.25% |
| 2021 Q2 | 322.4 Million USD | -11.91% |
| 2021 Q1 | 366 Million USD | 19316.66% |
| 2021 FY | 324.38 Million USD | -28.93% |
| 2021 Q4 | 338.31 Million USD | 2.34% |
| 2021 Q3 | 330.58 Million USD | 2.53% |
| 2020 Q4 | 1.88 Million USD | -99.59% |
| 2020 Q1 | 453.66 Million USD | -30.09% |
| 2020 Q2 | 458.85 Million USD | 1.14% |
| 2020 Q3 | 458.89 Million USD | 0.01% |
| 2020 FY | 456.41 Million USD | -29.8% |
| 2019 Q1 | 643.74 Million USD | 1.17% |
| 2019 Q4 | 648.92 Million USD | 1.16% |
| 2019 Q3 | 641.46 Million USD | -3.07% |
| 2019 FY | 650.17 Million USD | 2.18% |
| 2019 Q2 | 661.78 Million USD | 2.8% |
| 2018 Q4 | 636.29 Million USD | -22.02% |
| 2018 Q2 | 806.28 Million USD | 230.95% |
| 2018 Q1 | 243.62 Million USD | 0.1% |
| 2018 Q3 | 815.98 Million USD | 1.2% |
| 2018 FY | 636.29 Million USD | 161.43% |
| 2017 Q2 | 242.92 Million USD | 0.09% |
| 2017 FY | 243.38 Million USD | 0.38% |
| 2017 Q4 | 243.38 Million USD | 0.1% |
| 2017 Q3 | 243.15 Million USD | 0.1% |
| 2017 Q1 | 242.69 Million USD | 0.09% |
| 2016 Q3 | 242.25 Million USD | -0.01% |
| 2016 FY | 242.47 Million USD | 0.36% |
| 2016 Q4 | 242.47 Million USD | 0.09% |
| 2016 Q2 | 242.27 Million USD | 18.05% |
| 2016 Q1 | 205.23 Million USD | -0.52% |
| 2015 Q2 | 4.83 Million USD | -16.04% |
| 2015 Q1 | 5.75 Million USD | -97.12% |
| 2015 FY | 241.61 Million USD | 19.07% |
| 2015 Q4 | 206.3 Million USD | 4997.75% |
| 2015 Q3 | 4.04 Million USD | -16.21% |
| 2014 Q3 | 7.25 Million USD | 69.71% |
| 2014 Q2 | 4.27 Million USD | -16.04% |
| 2014 Q1 | 5.09 Million USD | -13.41% |
| 2014 FY | 202.92 Million USD | 3349.85% |
| 2014 Q4 | 199.53 Million USD | 2649.51% |
| 2013 FY | 5.88 Million USD | -34.66% |
| 2013 Q2 | 7.21 Million USD | -10.8% |
| 2013 Q3 | 6.58 Million USD | -8.73% |
| 2013 Q1 | 8.08 Million USD | -10.14% |
| 2013 Q4 | 5.88 Million USD | -10.68% |
| 2012 Q1 | 10.87 Million USD | 29.99% |
| 2012 FY | 9 Million USD | 7.59% |
| 2012 Q2 | 10.4 Million USD | -4.29% |
| 2012 Q3 | 9.52 Million USD | -8.53% |
| 2012 Q4 | 9 Million USD | -5.45% |
| 2011 Q3 | 9.17 Million USD | -7.0% |
| 2011 Q1 | 10.54 Million USD | -5.13% |
| 2011 Q2 | 9.86 Million USD | -6.51% |
| 2011 Q4 | 8.36 Million USD | -8.77% |
| 2011 FY | 8.36 Million USD | -24.74% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 11.11 Million USD | 0.0% |
| 2010 Q4 | 11.11 Million USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q2 | 25 Thousand USD | -53.7% |
| 2009 Q1 | 54 Thousand USD | -97.52% |
| 2008 Q4 | 2.17 Million USD | 1166.28% |
| 2008 Q3 | 172 Thousand USD | -35.34% |
| 2008 Q2 | 266 Thousand USD | -34.0% |
| 2008 Q1 | 403 Thousand USD | -35.73% |
| 2008 FY | 2.17 Million USD | 247.37% |
| 2007 Q2 | 1.25 Million USD | -23.28% |
| 2007 Q3 | 889 Thousand USD | -29.39% |
| 2007 Q4 | 627 Thousand USD | -29.47% |
| 2007 Q1 | 1.64 Million USD | -95.89% |
| 2007 FY | 627 Thousand USD | -98.43% |
| 2006 Q2 | 142.67 Million USD | -1.03% |
| 2006 Q4 | 39.9 Million USD | -71.98% |
| 2006 FY | 39.9 Million USD | -76.6% |
| 2006 Q3 | 142.43 Million USD | -0.17% |
| 2006 Q1 | 144.15 Million USD | -15.46% |
| 2005 Q3 | 170.53 Million USD | -0.37% |
| 2005 Q4 | 170.51 Million USD | -0.01% |
| 2005 FY | 170.51 Million USD | -0.52% |
| 2005 Q1 | 171.44 Million USD | 0.02% |
| 2005 Q2 | 171.16 Million USD | -0.16% |
| 2004 Q2 | 171.1 Million USD | -0.03% |
| 2004 Q1 | 171.14 Million USD | 0.0% |
| 2004 Q4 | 171.41 Million USD | 0.0% |
| 2004 FY | 171.41 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q1 | 158.95 Million USD | 84.54% |
| 2003 Q2 | 158.65 Million USD | -0.19% |
| 2003 FY | - USD | -100.0% |
| 2003 Q3 | 157.93 Million USD | -0.45% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | 33.63 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | 3.73 Million USD | 0.0% |
| 2002 Q4 | 86.13 Million USD | 2208.01% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -1382.727% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -178.923% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 16.87 Million USD | 63.469% |
| Café Serendipity Holdings, Inc. | 412.56 Thousand USD | -1394.306% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 272.02 Thousand USD | -2166.311% |
| HealthWarehouse.com, Inc. | 2.73 Million USD | -125.007% |
| MedGen, Inc. | 24.47 USD | -25194015.243% |
| Omni Health, Inc. | 1.84 Million USD | -234.828% |
| Oxford Investments Holdings Inc. | 207.06 Thousand USD | -2877.326% |
| Pineapple, Inc. | 8.1 Million USD | 23.978% |
| ScripsAmerica, Inc. | 1.2 Million USD | -412.551% |